Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000950170-24-073694

Options or other derivatives

  • Director acquired 47,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Klencke Barbara Director 2024-06-12 Grant or award · Stock Option (Right to Buy) +47,500 47,500 D
Loading xslF345X05/ownership.xml…